Happy Banana®
TCI’s Happy Banana® is a botanical ingredient derived from banana peel.
What is Happy Banana®?
TCI's Happy Banana® is a botanical ingredient developed from banana peel. Its extraction process retains naturally occurring banana peel compounds, including the marker compound Hydroxyanigorufone. Research continues to explore associations between banana peel extract, tryptophan metabolic pathways, and physiological indicators related to serotonin, melatonin, and circadian rhythm.
Happy Banana® is intended for food applications and can be evaluated for products related to sleep support, evening relaxation, and circadian rhythm product concepts. Final product claims, directions for use, and labeling should be determined according to the complete formulation, available scientific substantiation, and target-market regulations.
Benefits of Banana®
Awards

Silver Medal

Silver Medal

Silver Medal

Gold Medal

Special Award
Available Dosage Forms
Reference
- Lee HC, Lin YK, Lin YH, Chan ST, Chiang CF. Banana Peel Extract (Happy Banana®): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Depression & Anxiety. 2025;14:569.
Frequently Asked Questions
No. Happy Banana® does not contain added melatonin. It is a banana peel extract that can be evaluated for evening routine product concepts.
This describes findings on the ingredient's mechanism and is not a statement that a finished product regulates sleep. Claims depend on the complete formula and target-market regulations.
The clinical study used 200 mg/day, taken approximately 2 hours before bedtime. Significant benefits were observed after 4 weeks of continuous supplementation.
200 mg/day is the amount used under study conditions, not a recommended product dosage. The use level in a finished product depends on the format, the complete formula and target-market regulations.
Yes. Toxicology and clinical safety documentation for Happy Banana® is available to partners on request.
Safety documentation covers ingredient assessments carried out under specific study conditions and does not establish the safety of any finished product. Finished-product safety must be assessed by formula, use level and target market.
Happy Banana® has established edibility or commercialization pathways in multiple markets, including the United States, European Union, Taiwan, Malaysia, Indonesia, Vietnam, the Philippines, the United Arab Emirates, and Australia. Regulatory status documentation for each market is available to partners on request.
An NDI notification or a TGA ingredient listing is not an approval or an endorsement of efficacy. Market availability for a specific product depends on its formula, product category and local registration requirements.



